| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Fusion Pharmaceuticals Inc. | Chief Medical Officer | Restricted Stock Units | 0 | $0 | $2.03 | 04 Jun 2024 | Direct |
| Fusion Pharmaceuticals Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 0 | 04 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000095017024068889-bobilev-dmitri-2024-06-04 | Fusion Pharmaceuticals Inc. | 04 Jun 2024 | 3 | $0 | 4 | Chief Medical Officer | 04 Jun 2024, 17:23 |
| /report/000095017024002293-bobilev-dmitri-2024-01-04 | Fusion Pharmaceuticals Inc. | 04 Jan 2024 | 2 | $0 | 4 | Chief Medical Officer | 05 Jan 2024, 08:46 |
| /report/000120919122056027-bobilev-dmitri-2022-11-07 | Fusion Pharmaceuticals Inc. | 07 Nov 2022 | 1 | $0 | 4 | Chief Medical Officer | 07 Nov 2022, 18:29 |
| /report/000120919122056026-bobilev-dmitri-2022-11-07 | Fusion Pharmaceuticals Inc. | 07 Nov 2022 | 0 | $0 | 3 | Chief Medical Officer | 07 Nov 2022, 18:25 |